KRISTEN DICKINSON: Open Payments
NPI 1922265560 · SAREPTA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 17 payments from 9 companies in 2025. Trend: 2023 $380 · 2024 $286 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $88 |
| Tris Pharma Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, Dyanavel XR, KEVEYIS, TRELEGY ELLIPTA, ZEPBOUND, MOUNJARO, QULIPTA, FARXIGA.
Industry payments across LA — which companies pay providers there.
